<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandin</z:chebi> synthetase activity in rectal biopsy specimens from patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> has been shown to fall on treatment with sulphasalazine, local steroids, and <z:chebi fb="11" ids="16714">codeine</z:chebi> phosphate </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro studies have shown that sulphasalazine is an inhibitor of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> synthetase, although less potent than <z:chebi fb="0" ids="49662">indomethacin</z:chebi>, whereas <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="11" ids="16714">codeine</z:chebi> phosphate were inactive </plain></SENT>
<SENT sid="2" pm="."><plain>It is suggested that the therapeutic action of sulphasalazine may be related in part to its action in inhibiting <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> biosynthesis </plain></SENT>
</text></document>